Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297


The role of Syk in peripheral T cells.

Park JE, Majumdar S, Brand DD, Rosloniec EF, Yi AK, Stuart JM, Kang AH, Myers LK.

Clin Immunol. 2018 Jul;192:50-57. doi: 10.1016/j.clim.2018.04.007. Epub 2018 Apr 16.


Pediatric Weight Errors and Resultant Medication Dosing Errors in the Emergency Department.

Hirata KM, Kang AH, Ramirez GV, Kimata C, Yamamoto LG.

Pediatr Emerg Care. 2019 Sep;35(9):637-642. doi: 10.1097/PEC.0000000000001277.


Systematic Proteogenomic Approach To Exploring a Novel Function for NHERF1 in Human Reproductive Disorder: Lessons for Exploring Missing Proteins.

Na K, Shin H, Cho JY, Jung SH, Lim J, Lim JS, Kim EA, Kim HS, Kang AR, Kim JH, Shin JM, Jeong SK, Kim CY, Park JY, Chung HM, Omenn GS, Hancock WS, Paik YK.

J Proteome Res. 2017 Dec 1;16(12):4455-4467. doi: 10.1021/acs.jproteome.7b00146. Epub 2017 Nov 1.


The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Kim S, Easterling ER, Price LC, Smith SL, Coligan JE, Park JE, Brand DD, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

J Immunol. 2017 Oct 15;199(8):2692-2700. doi: 10.4049/jimmunol.1700271. Epub 2017 Sep 8.


Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.

Park JE, Rotondo JA, Cullins DL, Brand DD, Yi AK, Stuart JM, Kang AH, Myers LK.

J Immunol. 2016 Dec 15;197(12):4569-4575. Epub 2016 Nov 11.


Multimodal game bot detection using user behavioral characteristics.

Kang AR, Jeong SH, Mohaisen A, Kim HK.

Springerplus. 2016 Apr 26;5:523. doi: 10.1186/s40064-016-2122-8. eCollection 2016.


Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Myers LK, Cullins DL, Park JE, Yi AK, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Clin Immunol. 2015 Oct;160(2):188-97. doi: 10.1016/j.clim.2015.05.002. Epub 2015 May 14.


Extent and divergence of heteroplasmy of the DNA barcoding region in Anapodisma miramae (Orthoptera: Acrididae).

Kang AR, Kim MJ, Park IA, Kim KY, Kim I.

Mitochondrial DNA A DNA Mapp Seq Anal. 2016 Sep;27(5):3405-14. doi: 10.3109/19401736.2015.1022730. Epub 2015 Apr 2.


Acute exacerbation of dysphagia due to foreign body impaction in an oesophageal stricture due to eosinophilic esophagitis.

Kang JY, Kang AH, Amin Z, Chong H.

BMJ Case Rep. 2015 Mar 12;2015. pii: bcr2014208616. doi: 10.1136/bcr-2014-208616.


Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.

Jun Y, Kang AR, Lee JS, Park SJ, Lee DY, Moon SH, Lee SH.

Biomaterials. 2014 Jun;35(17):4815-26. doi: 10.1016/j.biomaterials.2014.02.045. Epub 2014 Mar 15.


Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.

Tang B, Kim S, Hammond S, Cullins DL, Brand DD, Rosloniec EF, Stuart JM, Postlethwaite AE, Kang AH, Myers LK.

Arthritis Res Ther. 2014 Jan 10;16(1):R7. doi: 10.1186/ar4433.


Microfluidics-generated pancreatic islet microfibers for enhanced immunoprotection.

Jun Y, Kim MJ, Hwang YH, Jeon EA, Kang AR, Lee SH, Lee DY.

Biomaterials. 2013 Nov;34(33):8122-30. doi: 10.1016/j.biomaterials.2013.07.079. Epub 2013 Aug 5.


Systematic review: worldwide variation in the frequency of coeliac disease and changes over time.

Kang JY, Kang AH, Green A, Gwee KA, Ho KY.

Aliment Pharmacol Ther. 2013 Aug;38(3):226-45. doi: 10.1111/apt.12373. Epub 2013 Jun 18. Review.


3D co-culturing model of primary pancreatic islets and hepatocytes in hybrid spheroid to overcome pancreatic cell shortage.

Jun Y, Kang AR, Lee JS, Jeong GS, Ju J, Lee DY, Lee SH.

Biomaterials. 2013 May;34(15):3784-94. doi: 10.1016/j.biomaterials.2013.02.010. Epub 2013 Feb 21.


Surface tension-mediated, concave-microwell arrays for large-scale, simultaneous production of homogeneously sized embryoid bodies.

Jeong GS, Song JH, Kang AR, Jun Y, Kim JH, Chang JY, Lee SH.

Adv Healthc Mater. 2013 Jan;2(1):119-25. doi: 10.1002/adhm.201200070. Epub 2012 Jul 13.


Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Kimata M, Cullins DL, Brown ML, Brand DD, Rosloniec EF, Myers LK, Stuart JM, Kang AH.

Arthritis Res Ther. 2012 May 8;14(3):R107. doi: 10.1186/ar3832.


Molecular basis for T cell response induced by altered peptide ligand of type II collagen.

Park JE, Cullins D, Zalduondo L, Barnett SL, Yi AK, Kleinau S, Stuart JM, Kang AH, Myers LK.

J Biol Chem. 2012 Jun 1;287(23):19765-74. doi: 10.1074/jbc.M112.349688. Epub 2012 Apr 16.


Analysis of context dependence in social interaction networks of a massively multiplayer online role-playing game.

Son S, Kang AR, Kim HC, Kwon T, Park J, Kim HK.

PLoS One. 2012;7(4):e33918. doi: 10.1371/journal.pone.0033918. Epub 2012 Apr 4.


Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.

Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ.

Clin Immunol. 2011 Dec;141(3):328-37. doi: 10.1016/j.clim.2011.08.014. Epub 2011 Sep 2.


Therapeutic target achievement in type 2 diabetic patients after hyperglycemia, hypertension, dyslipidemia management.

Kang AY, Park SK, Park SY, Lee HJ, Han Y, Lee SR, Suh SH, Kim DK, Park MK.

Diabetes Metab J. 2011 Jun;35(3):264-72. doi: 10.4093/dmj.2011.35.3.264. Epub 2011 Jun 30.


T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Myers LK, Cullins DL, Brand DD, Kleinau S, Stuart JM, Kang AH.

Arthritis Rheum. 2011 Sep;63(9):2661-70. doi: 10.1002/art.30454.


Microfluidic assay of endothelial cell migration in 3D interpenetrating polymer semi-network HA-Collagen hydrogel.

Jeong GS, Kwon GH, Kang AR, Jung BY, Park Y, Chung S, Lee SH.

Biomed Microdevices. 2011 Aug;13(4):717-23. doi: 10.1007/s10544-011-9541-7.


Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.

Tang B, Cullins DL, Zhou J, Zawaski JA, Park H, Brand DD, Hasty KA, Gaber MW, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2010;12(4):R136. doi: 10.1186/ar3074. Epub 2010 Jul 8.


Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma).

Atamas SP, Luzina IG, Ingels J, Choi J, Wong WK, Furst DE, Clements PJ; Investigators of the Oral Collagen Trial in Scleroderma, Postlethwaite AE.

Clin Exp Immunol. 2010 Sep;161(3):426-35. doi: 10.1111/j.1365-2249.2010.04189.x.


Collagen-induced arthritis.

Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD.

Curr Protoc Immunol. 2010 Apr;Chapter 15:Unit 15.5.1-25. doi: 10.1002/0471142735.im1505s89.


T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.

Tang B, Zhou J, Park JE, Cullins D, Yi AK, Kang AH, Stuart JM, Myers LK.

Clin Immunol. 2009 Oct;133(1):145-53. doi: 10.1016/j.clim.2009.06.006.


Accuracy of a reformulated fast-set vinyl polysiloxane impression material using dual-arch trays.

Kang AH, Johnson GH, Lepe X, Wataha JC.

J Prosthet Dent. 2009 May;101(5):332-41. doi: 10.1016/S0022-3913(09)60066-4.


Genetic and molecular basis of quantitative trait loci of arthritis in rat: genes and polymorphisms.

Xiong Q, Jiao Y, Hasty KA, Stuart JM, Postlethwaite A, Kang AH, Gu W.

J Immunol. 2008 Jul 15;181(2):859-64.


A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M, Merkel PA, Molitor JA, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst DE.

Arthritis Rheum. 2008 Jun;58(6):1810-22. doi: 10.1002/art.23501.


An altered peptide ligand of type II collagen suppresses autoimmune arthritis.

Myers LK, Tang B, Rosioniec EF, Stuart JM, Kang AH.

Crit Rev Immunol. 2007;27(4):345-56.


The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances.

Ye XJ, Tang B, Ma Z, Zhou J, Myers LK, Kang AH, Cremer MA.

Clin Exp Immunol. 2007 Sep;149(3):553-60. Epub 2007 Jul 10.


Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil.

Kang AY, Baek YH, Sohn YJ, Lee SK, Son CH, Kim K, Yang DK.

Korean J Intern Med. 2006 Dec;21(4):240-3.


Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2006;8(5):R150.


Characterisation of the immune response to type I collagen in scleroderma.

Warrington KJ, Nair U, Carbone LD, Kang AH, Postlethwaite AE.

Arthritis Res Ther. 2006;8(4):R136.


The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice.

Myers LK, Bhattacharya SD, Herring PA, Xing Z, Goorha S, Smith RA, Bhattacharya SK, Carbone L, Faccio R, Kang AH, Ballou LR.

Bone. 2006 Nov;39(5):1048-1052. doi: 10.1016/j.bone.2006.05.015. Epub 2006 Jul 27.


Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar.

Sakurai Y, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Immunology. 2006 Jan;117(1):136-42.


Effects of a low sodium diet on bone metabolism.

Carbone LD, Barrow KD, Bush AJ, Boatright MD, Michelson JA, Pitts KA, Pintea VN, Kang AH, Watsky MA.

J Bone Miner Metab. 2005;23(6):506-13.


[Prognostic factors and survival according to the Okuda stage in patients with hepatocellular carcinoma].

Kim JH, Han SY, Kang AY, Shon YJ, Koo YH, Ryu SH, Cho JH, Han SH, Lee SW, Jang JS, Lee JH, Roh MH, Choi SR.

Korean J Gastroenterol. 2005 Oct;46(4):283-90. Korean.


Traumatic spinal cord injury.

Kang AH.

Clin Obstet Gynecol. 2005 Mar;48(1):67-72. Review. No abstract available.


Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope location.

Tang B, Brand DD, Ma Z, Stuart JM, Myers LK, Kang AH.

Immunology. 2004 Nov;113(3):384-91.


Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.

Myers LK, Tang B, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Arthritis Rheum. 2004 Sep;50(9):3004-11.


Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.

Van den Steen PE, Proost P, Brand DD, Kang AH, Van Damme J, Opdenakker G.

Biochemistry. 2004 Aug 24;43(33):10809-16.


The mouse model of collagen-induced arthritis.

Brand DD, Kang AH, Rosloniec EF.

Methods Mol Med. 2004;102:295-312.


T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.

He X, Rosloniec EF, Myers LK, McColgan WL 3rd, Gumanovskaya M, Kang AH, Stuart JM.

Arthritis Rheum. 2004 Jun;50(6):1996-2004.


The roles of interleukin-18 in collagen-induced arthritis in the BB rat.

Ye XJ, Tang B, Ma Z, Kang AH, Myers LK, Cremer MA.

Clin Exp Immunol. 2004 Jun;136(3):440-7.


An analog peptide that suppresses collagen-induced arthritis.

Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH.

Am J Med Sci. 2004 Apr;327(4):212-6.


Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).

Rosloniec EF, Whittington KB, He X, Stuart JM, Kang AH.

Am J Med Sci. 2004 Apr;327(4):169-79.


Supplemental Content

Loading ...
Support Center